Navigation Links
Gene Therapy Brings New Muscle to Monkeys
Date:11/12/2009

Finding holds hope of better treatment for muscular dystrophy, experts say

THURSDAY, Nov. 12 (HealthDay News) -- Researchers are reporting that injections of genes into the leg muscles of monkeys helped the animals gain muscle size and strength without side effects.

The Muscular Dystrophy Association, which funded the research, said the gene-therapy findings, though preliminary, might someday lead to better treatment for people who suffer from muscle loss.

The macaque monkeys were given injections of genes for a protein known as follistatin.

"It's exciting to see profound improvement in muscle size and strength with no adverse effects on any organs or systems, including the heart," Dr. R. Rodney Howell, chairman of the association's board, said in a news release from the group. "Improvement in treated thigh muscle is noteworthy because the large muscle is so important when people sit, rise from sitting and for mobility."

The report was published Nov. 11 in Science Translational Medicine.

Researchers are trying to boost muscle growth by blocking the protein myostatin. Injecting genes for follistatin appears to be one way of doing that.

There are some caveats, however. For one thing, the monkeys in the study did not have a muscle disease. But the researchers suspect that the gene therapy will still help those who do.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about muscular dystrophy.



-- Randy Dotinga



SOURCE: Muscular Dystrophy Association, news release, Nov. 11, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION ANV Therapy System in Europe Following Commercialization
2. Reportlinker Adds North America Negative Pressure Wound Therapy (NPWT) Market: Strategic Market Analysis and Insight to 2012
3. Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism
4. U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
5. St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial
6. UCI embryonic stem cell therapy restores walking ability in rats with neck injuries
7. St. Jude Childrens Research Hospital and UF Proton Therapy Institute to Begin Proton Therapy Clinical Trial
8. Radiation Therapy Options for Mesothelioma Patients Sponsored by MesoCare.org
9. PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
10. Radiation Therapy Options in Mesothelioma by Veronica Garza of MD Anderson Sponsored by MesoCare.org
11. Anodyne Therapy, LLC Develops Device For Treatment of Foot and Leg Pain And Pledges Donation In Honor Of World Diabetes Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... 06, 2016 , ... From May 4 to 6, EarQ and ... opportunity to learn more about Signia’s technology and the successful business and marketing techniques ... priority to see practices succeed in this highly competitive industry,” said Ed Keller, president ...
(Date:5/6/2016)... Arizona (PRWEB) , ... May 06, 2016 , ... ... moved domains to Sleepopolis.com . , Since launching in September, 2014 Sleepopolis ... research and testing areas, which now include pillows, sheets, mattress toppers, bed frames, ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... online provider of career-focused education and corporate training, and the National Military Family ... to announce Maritza Aquino as the second full-tuition scholarship recipient of 2016. ...
(Date:5/6/2016)... ... May 06, 2016 , ... RowdMap, Inc. ... Cross BlueShield and Former Principal Deputy Administrator at Centers for Medicare and Medicaid ... Steve Ondra, MD, Chief Medical Officer at Health Care Service Corporation (Blue Cross ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , ... a development collaboration with the Australian critical medicine company, Phebra Pty Ltd. ... , LAI medicines can offer improved therapeutic benefits over oral formulations, including better ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research and Markets has announced ... in the USA"  report to their offering.  ,     (Logo: ... the current Positron Emission Tomography (PET) scanner and cyclotron ... market. Along with the current known number of PET ... , the report also contains a detailed breakdown of ...
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocytopenia Market and ... to their offering.       ... ,The latest research Europe Thrombocytopenia Market ... provides comprehensive insights into Thrombocytopenia pipeline ...
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
Breaking Medicine Technology: